Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial

Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial

Patients with cancer have high risks of venous thromboembolism (VTE) as well as thrombocytopenia. Thrombocytopenia is associated with an increased risk of bleeding. Hence, treatment of acute VTE with anticoagulation is challenging in patients with cancer and thrombocytopenia. Data are limited in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Tzu–Fei Wang, Mari Thomas, Andrea Cervi, Yishi Tan, Cynthia Wu, Avi Leader, Luis Jara–Palomares, Simon J. Stanworth, Marc Carrier
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
low-molecular-weight heparin
neoplasms
randomized
thrombocytopenia
venous thrombosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037925002225
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items